The experiments using clinical HNSCC samples demonstrated that GALR1 methylation was significantly correlated with reduced survival rates, tumor stage, lymph node status, increased tumor size, cyclin D1 expression and p16 methylation [38]. Here, GALR1 is linked to neoplasm.